Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: In-hospital and long-term clinical outcomes

Coronary Artery Disease

Volumn 22, Issue 6, 2011, Pages 375-379

  Ayhan, Erkan ^a   Aycicek, Fatih ^a   Uyarel, Huseyin ^b   Ergelen, Mehmet ^b   Cicek, Gokhan ^a   Gul, Mehmet ^a   Osmonov, Damirbek ^a   Yildirim, Ersin ^a   Bozbay, Mehmet ^a   Ugur, Murat ^a   Işik, Turgay ^a   Tezel, Tuna ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

Author keywords

acute myocardial infarction; anemia; primary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; STATIN;

ADULT; AGED; ANEMIA; ANGIOPLASTY; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; FEMALE; HEART DISEASES; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT ADMISSION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 80051783596     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283472ac5     Document Type: Article

References (14)

1. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 2004;44:547-553. (Pubitemid 39078177)
2. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-2049. (Pubitemid 40577898)
3. Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR, et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010;105:1385-1394.
4. Kurek T, Lenarczyk R, Kowalczyk J, Swiatkowski A, Kowalski O, Stabryla-Deska J, et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2010;105:611-618.
5. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786. (Pubitemid 34595288)
6. Okonko DO, Anker SD. Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail 2004;10(1 Suppl):S5-S9. (Pubitemid 38879389)
7. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003;90:303-308. (Pubitemid 37087891)
8. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004;110:271-277. (Pubitemid 38955496)
9. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002;359:1747-1748. (Pubitemid 34607091)
10. Şen N, Yazici HU, Tavil Y, Poyraz F, Turfan M, Aygül N, et al. The relationship between admission hemoglobin level and left ventricular systolic functions in patients with first ST-segment elevated myocardial infarction. Archives of the Turkish Society of Cardiology 2010;38:233-238.
11. Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J 2009;30:1331-1339.
12. Steinvil A, Banai S, Leshem-Rubinow E, Rogowski O, Halkin A, Keren G, et al. The development of anemia of inflammation during acute myocardial infarction. Int J Cardiol 2010. doi:10.1016/j.ijcard.2010.10.031.
13. Vis MM, Sjauw KD, Van der Schaaf RJ, Koch KT, Baan J Jr. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. Am J Cardiol 2007;99:1201-1202. (Pubitemid 46659854)
14. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction: national registry of myocardial infarction 2 participants. N Engl J Med 1999;341:217-225. (Pubitemid 29334519)